HCPCS G8126: Major Depression Treated with Antidepressant for 12-Week Acute Phase - OpenPayer

Summary & Overview

HCPCS G8126: Major Depression Treated with Antidepressant for 12-Week Acute Phase

HCPCS Level II code G8126 represents documentation that a patient diagnosed with major depression was treated with antidepressant medication throughout the entire 84-day (12-week) acute treatment phase. This measure is clinically important because sustained adherence to antidepressant therapy during the acute phase is associated with improved symptom response and decreased risk of relapse. National attention on behavioral health quality and medication adherence makes this code relevant for payers and providers tracking performance and outcomes.

Key payers included in this discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical intent, typical service settings, and the types of benchmarks and reporting that commonly accompany similar adherence and treatment-continuation measures. The publication outlines the clinical context for use, implications for outpatient and primary care management, and the common reporting frameworks tied to HCPCS Level II performance measures.

This summary provides a national perspective on why documentation captured by G8126 matters for quality measurement and continuity of care. Data not available in the input will be noted where specific payer policies, modifiers, taxonomies, ICD-10 diagnoses, related codes, or service-line details would otherwise appear.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG8126HCPCS Level IImajor depressionantidepressant adherencebehavioral healthacute treatment phasemedication managementquality measure

Billing Code Overview

HCPCS Level II code G8126 documents a patient diagnosed with major depression who was treated with antidepressant medication for the entire 84-day (12-week) acute treatment phase. This code captures completion of the acute treatment phase under pharmacologic management for major depressive disorder.

Service type: Pharmacologic treatment monitoring and documentation during an acute depression treatment episode
Typical site of service: Outpatient behavioral health settings, primary care clinics, telehealth follow-up, or other ambulatory care environments where medication management and follow-up for depression are provided

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 38-year-old patient with a documented diagnosis of major depressive disorder presents for routine follow-up in an outpatient behavioral health clinic. The clinician documents that the patient has been prescribed a therapeutic antidepressant (for example, an SSRI, SNRI, or bupropion) and has been taking the medication continuously for the entire 84-day (12-week) acute treatment phase. The clinical workflow includes an initial diagnostic assessment, initiation or continuation of pharmacotherapy, medication reconciliation at each visit, documentation of adherence and tolerability, periodic assessment of depressive symptoms (PHQ-9 or equivalent), and care coordination with primary care when indicated. The practice’s billing staff assigns G8126 to indicate that the patient with major depression was treated with an antidepressant for the full 84-day acute treatment phase, and supporting documentation is retained in the medical record including medication lists, refill history, visit notes, and symptom monitoring scores.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service	Use when an E/M visit is distinct and above the typical services associated with the behavioral treatment documented for the visit.

HCPCS G9502: Documentation of Medical Reason for Not Performing Foot Exam

HCPCS-G9699-LONG-ACTING-INHALED-BRONCHODILATOR-NOT-PRESCRIBED

HCPCS G9699: Long-Acting Inhaled Bronchodilator Not Prescribed

HCPCS-G9935-SCREENING-COLONOSCOPY-NO-ADENOMA-OR-COLORECTAL-CANCER-DETECTED

HCPCS G9935: Screening Colonoscopy, No Adenoma or Colorectal Cancer Detected

HCPCS-G9436-ASPIRIN-NOT-PRESCRIBED-DOCUMENTED-REASON

HCPCS G9436: Aspirin Not Prescribed for Documented Reasons

HCPCS-G9880-MDPP-5-PERCENT-WEIGHT-LOSS-OUTCOME

HCPCS G9880: MDPP 5% Weight Loss Outcome Payment

HCPCS-G9683-NURSING-FACILITY-ACUTE-FLUID-ELECTROLYTE-TREATMENT

HCPCS G9683: Onsite Acute Treatment for Fluid/Electrolyte Disorders

HCPCS-G8673-NECK-CRANIUM-MANDIBLE-THORACIC-SPINE-FUNCTIONAL-RESIDUAL-SCORE-NOT-MEASURED

HCPCS G8673: Risk-Adjusted Functional Status Residual Score Not Measured

HCPCS-G8569-PROLONGED-POSTOPERATIVE-INTUBATION-OVER-24-HOURS

HCPCS G8569: Prolonged Postoperative Intubation (>24 hours)

HCPCS-G0011-PREP-COUNSELING-HIV-RISK-REDUCTION-ADHERENCE

HCPCS G0011: Individual PrEP Counseling, HIV Risk Assessment

HCPCS-G9968-PATIENT-REFERRED-TO-SPECIALIST

HCPCS G9968: Patient Referred to Another Clinician or Specialist

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`103K00000X`	Psychiatrist	Psychiatrists commonly manage diagnosis, medication selection, and longitudinal pharmacotherapy for major depressive disorder.
`2084P0800X`	Nurse Practitioner - Psychiatry & Mental Health	Psychiatric NPs often provide medication management and follow-up for antidepressant therapy.
`367500000X`	Clinical Social Worker	Clinical social workers frequently provide psychotherapy and coordinate care; they may document progress relevant to treatment adherence.
`207Q00000X`	Physician Assistant - Psychiatry	PAs in psychiatry provide medication management and follow-up visits under supervising physician arrangements.
`208000000X`	Family Medicine Physician	Primary care physicians commonly initiate and continue antidepressant treatment and document the 12-week acute treatment phase.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F32.9`	Major depressive disorder, single episode, unspecified	Commonly used for patients treated with antidepressant medication during an acute 12-week phase.
`F33.1`	Major depressive disorder, recurrent, moderate	Represents recurrent depressive episodes requiring continued antidepressant therapy and monitoring over the acute treatment period.
`F33.2`	Major depressive disorder, recurrent severe without psychotic features	Indicates severe recurrent depression where adherence to a full acute treatment course is clinically important.
`F32.1`	Major depressive disorder, single episode, moderate	Used when documenting the severity level during the acute treatment phase and guiding medication decisions.
`F33.0`	Major depressive disorder, recurrent, mild	Relevant for patients on antidepressant therapy whose severity is mild but still requires documented treatment adherence.
`F34.1`	Dysthymia (persistent depressive disorder)	Chronic depressive disorders sometimes overlap with treatment courses and may require continuous pharmacotherapy documented over extended periods.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly used for routine follow-up medication management visits during the 12-week treatment phase where clinicians assess adherence and response.
`99214`	Office or other outpatient visit for the evaluation and management of an established patient, typically 25 minutes	Used for more complex medication management visits with moderate complexity decision making or extensive counseling about depressive symptoms and treatment.
`96127`	Brief emotional/behavioral assessment (e.g., depression inventory) with scoring and documentation, per standardized instrument	Used for quick symptom monitoring such as a PHQ-9 single-item screener or comparable brief instrument during follow-up.
`90791`	Psychiatric diagnostic evaluation (no medical services)	Used for initial diagnostic assessment when major depressive disorder is first assessed and medication initiation is considered.
`99441`	Telephone evaluation and management service provided by a physician to an established patient, parent, or guardian, 5-10 minutes of medical discussion	May be used for telephonic medication management or adherence check-ins during the acute treatment phase when permitted by payer rules.

OpenPayer